ING Knock-Out UCB/ DE000NG8UJ44 /
| 2024-08-01 4:42:20 PM | Chg.+0.280 | Bid5:29:06 PM | Ask5:29:06 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 8.010EUR | +3.62% | - Bid Size: - |
- Ask Size: - |
UCB SA | 76.4493 EUR | 2078-12-31 | Call |
GlobeNewswire
06-28
United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire
06-04
Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire
06-04
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire
06-03
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire
05-09
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
05-01
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-15
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire
04-01
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
03-25
Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire
03-05
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
03-05
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
02-28
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
02-16
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire
02-08
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire
01-22
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire
01-15
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire
01-07
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire
2023-12-08
General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs
GlobeNewswire
2023-11-14
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
GlobeNewswire
2023-11-14
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
2023-11-13
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanom...
